◆英語タイトル:Genomic Health Inc (GHDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9823
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer test and Oncotype SEQ Liquid Select liquid biopsy mutation panel. Genomic Health develops these products using its Oncotype IQ Genomic Intelligence Platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in North America, Europe and Asia through direct offices, subsidiaries and distributors. Genomic Health is headquartered in Redwood City, California, the US.
Genomic Health Inc (GHDX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genomic Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genomic Health Inc, Medical Devices Deals, 2012 to YTD 2018 9
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genomic Health Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Epic Sciences Raises USD52 Million in Series E Financing 11
Station X Raises US$5 Million In Second Round Of Venture Financing 13
Partnerships 14
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 14
Genomic Health Enters into Research Agreement with Janssen Pharma 16
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 17
Equity Offering 18
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million 18
Genomic Health Inc – Key Competitors 19
Genomic Health Inc – Key Employees 20
Genomic Health Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 02, 2018: Genomic Health reports second quarter 2018 financial results 22
May 02, 2018: Genomic Health Reports First Quarter 2018 Financial Results 24
Mar 08, 2018: Genomic Health Announces 2017 Fourth Quarter and Year-end Financial Results, Provides 2018 Financial Outlook 26
Nov 08, 2017: Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress 28
Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress 30
May 09, 2017: Genomic Health Announces First Quarter 2017 Financial Results and Reports Recent Business Progress 32
Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Genomic Health Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genomic Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genomic Health Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Genomic Health Inc, Medical Devices Deals, 2012 to YTD 2018 9
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Epic Sciences Raises USD52 Million in Series E Financing 11
Station X Raises US$5 Million In Second Round Of Venture Financing 13
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 14
Genomic Health Enters into Research Agreement with Janssen Pharma 16
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 17
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million 18
Genomic Health Inc, Key Competitors 19
Genomic Health Inc, Key Employees 20
Genomic Health Inc, Other Locations 21
Genomic Health Inc, Subsidiaries 21
List of Figures
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genomic Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genomic Health Inc, Medical Devices Deals, 2012 to YTD 2018 9